Enzyme-linked immunosorbent assays which are based on species-or type-specific glycolipid antigens and in which rabbit antisera are prepared with homologous strains are capable of distinguishing among serological variants of the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex, Mycobacterium chelonei subspecies chelonei and abscessus, Mycobacterium simiae I and Il, Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium xenopi, and Mycobacterium fortuitum biovariant peregrinum. The immunoreactive glycolipids can be divided into two classes. Those resistant to alkali, the C-mycoside glycopeptidolipids, are present in the M. avium-M. intracellulare-M. scrofulaceum, the M. chelonei subspecies chelonei and abscessus, and the M. simiae I and II complexes and in M. fortuitum biovariant peregrinum. The alkali-labile glycolipid antigens, the lipooligosaccharides, are present in M. kansasii, M. szulgai, and M. xenopi. In one study, the combination of enzyme-linked immunosorbent assay and alkaline susceptibility was compared with seroagglutination in the identification of 60 clinical isolates of nontuberculous mycobacteria: 45 showed perfect concordance, 9 could be narrowed to one, two, or three possibilities, and the rest did not correspond. In a second study involving 43 clinical isolates that were untypable by seroagglutination or were autoagglutinable, the results of enzyme-linked immunosorbent assay and thin-layer chromatography of glycolipid antigens were compared: 21 showed clear concordance. The results demonstrate that enzyme-linked immunosorbent assay is particularly useful in assessing the antigenicity of lipids, and sensitivity, ease, and rapidity recommend it as an adjunct to seroagglutination and thin-layer chromatography for the identification of nontuberculous mycobacteria.
For the past few years, workers in our laboratories have determined the structures of the specific serotyping antigens of the clinically important mycobacteria. In all species examined to date, the specific antigens were found to be glycolipid in nature: those from the Mycobacterium aviumMycobacterium intracellulare-Mycobacterium scrofulaceum (MAIS) complex are C-mycoside glycopeptidolipids (2, 3) , those from Mycobacterium kansasii are trehalose-containing lipooligosaccharides (8) , and those from Mycobacterium leprae are triglycosylphenolic diacylphthiocerols (6, 7, 9) . For these studies, lipid from different species was extracted and fractionated, and the fractions were examined for serological activity with rabbit antiserum raised against the homologous strain of bacteria. Immunoreactive substances were then purified and the chemical structures were determined.
In recent studies, knowledge of the chemical structures of the specific antigens has been applied to the rapid detection and identification of nontuberculous mycobacteria of clinical importance. For this purpose the mycobacteria may be divided into two groups: those with alkali-stable glycolipids and those with alkali-labile glycolipids (4) . In the species with alkali-stable glycolipids, the C-mycosides are characterized by a fatty acyl function that is amide linked to the amino terminal of the peptide moiety, and therefore, the glycolipids survive alkalinolysis. This property has been used to aid in the identification of human isolates of the MAIS complex on the basis of thin-layer chromatography (TLC) profiles of the alkali-stable lipid extracts (4, 5, 14 (14) . The identity of each isolate had been established by seroagglutination and confirmed by TLC (14) . Other mycobacteria were obtained from the Trudeau Mycobacterial Culture Collection, also maintained at National Jewish Hospital.
Mycobacteria were grown on 7H11 agar at 37°C (3). Rapidly growing strains were harvested within 7 to 10 days, and slow growers were harvested after 3 weeks in phenolized phosphate-buffered saline as described previously (14) . The " Cross-reacting antibodies were agglutinated by the serovar in parentheses, as described by Schaefer (11) . CH30H (2:1, vol/vol) for 10 to 15 s and heating in a 50°C water bath for 18 h (5). The CHCl3-CH30H extracts were used directly or were treated with mild alkali (5) .
ELISA. Absolute ethanol in the amounts described below was added to lipid preparations which were sonicated in a sonic bath (Ultramet III; Buehler Ltd., Evanston, Ill.) until they appeared homogeneous. A 50-,ul sample of the lipid suspension was applied to flat-bottomed wells of 96-well polystyrene microtiter plates (Linbro enzyme immunoassay plates; Flow Laboratories, Inc., McLean, Va.). Plates were dried overnight, followed by a 10-min block with phosphatebuffered saline (0.09 M Na2HP04, 0.02 M NaH2PO4, 0.01 M NaCl, pH 7.4) containing 0.1% Tween 80. Rabbit antiserum (50 ,ul) against homologous strains of mycobacteria (11, 14) , diluted in phosphate-buffered saline-Tween 80, was added to each well. Plates were incubated for 30 min in a humid chamber at room temperature. Serum was aspirated and plates were washed four times, 5 min per wash, with phosphate-buffered saline. NL . : ' ' ' L '9:s ;s`>S:i sz ,» ;w ,Z t # ,#st ss, ,,w@sui*,5ts E t~~~~~~~~~~~~l / v e i -y w P w S S . v j * * t * * p 9 o z 4 > > . ,X -N « e ; 2 (14) .
RESULTS AND DISCUSSION ELISA and glycolipid antigens of MAIS complex serovars. Strains and antisera used in this study are listed in Table 1 . All were from a recently established, authenticated collection (14) . Alkali treatment of total lipid extract from MAIS complex serovars resulted in degradation of glycerides, and the resulting lipid preparation contained only the serologically active glycopeptidolipids, unreactive fatty acids, and some nonsaponifiable lipids (3). Thus, alkali treatment reduced the possibility of nonspecific reactions. Throughout this study, alkali-stable whole-lipid preparations were used instead of pure glycolipid antigens, which are more difficult to derive. The amounts used in the assays shown in Fig. 1 are listed in Table 1 . Subsequent work, however, led to the development of one standard antigen concentration (8.4 ,ug/ml) with a variable antibody dilution for purposes of identifying unknown clinical isolates. The cross-reactive patterns described below remained the same at this concentration.
The reactions shown in Fig. 1 represent one of eight complete assays in which glycolipids from the authenticated serovars were used. The combinations with good specificity or sizable cross-reactivity are demonstrated. In other assays, the absolute color development often varied. However, both specific and cross-reacting pairs always behaved consistently, indicating that cross-reactivities were absolute. Antiserum to serovar 3 reacted strongly with antigens of serovars 3 and 9 but also with antigens of serovars Schaefer (12) and Meissner and Anz (10), who used whole-cell agglutination. One reason for the absence of conformity may be due to the extraction of shared glycolipid antigens, perhaps cryptic in the intact cell. Indeed, examination of published TLC profiles of the glycolipid antigens shows evidence in several instances of common, minor, presumed antigenic glycolipids (4, 14) . For instance, the glycolipid pattern of serovar 3 always shows a minor component that is chromatographically indistinguishable from antigen Il of serovar 9 (3, 14) .
Absorbance values in these assays are dependent upon several conditions. First, sera and conjugate tend to decrease in reactivity over an extended period of time and hence diminish absorbance readings. The pH of each buffer used in washing, diluting conjugate, and preparing substrate is of critical importance; slight deviations in pH, especially that of the citrate phosphate buffer, showed marked decrease in speed and degree of color change. Slight variations in incubation periods and times of washing also have an additive effect. This problem can be compensated for by use of a set standard for each ELISA performed; the corrected absorbance for each sample is then calculatable (15) . Furthermore, since similar cross-reactive patterns are apparent, this may be used for identification.
The results of a blind study in which glycolipid from clinical isolates was used as the solid-phase antigen are shown in Table 2 . Of 60 isolates that had been typed by seroagglutination, 45 were correctly identified by ELISA. A further nine could be narrowed to one of two or three possibilities, but the results on the remaining six did not correspond to those from seroagglutination. In another study, 43 clinical isolates which were untypable or autoagglutinable in seroagglutination were examined, this time by both TLC and ELISA. Of the 43 samples, 21 typed identically, whereas 10 showed conflicting results. Eight remained untypable by both methods. In the case of another three samples, ELISA provided a clear identification, but no distinct TLC pattern was seen. One isolate showed a distinct TLC pattern but no ELISA response.
Thus, a feature of ELISA in the present context is the ability to allow division of mycobacteria into typable and untypable strains; the ill-defined category "spontaneous agglutination" (12) is not applicable. Although there were incidences in which results with the various procedures did not correspond, the degree of concordance and homologous reactivity was such as to indicate that ELISA in a simple format without the need for extensive glycolipid purification and with the potential for great sensitivity is another useful technique for identifying the ubiquitous MAIS complex serovars.
ELISA and the glycolipid antigens of other mycobacteria. Details of strains and sera are described in the footnotes to might not be glycolipid. The glycolipids of M. fortuitum biovariant peregrinum were antigenic but showed considerable cross-reactivity with glycolipids from heterologous species (data not shown).
To better define the antigens responsible for these activities, we treated CHCl3-CH30H-extracted lipids with alkali and chromatographed the products in the organic phase on thin-layer plates in CHCl3-CH30H-H20 (65:25:4, vol/vol/vol) and sprayed them with orcinol-sulfuric acid. The presence of alkali-stable lipids on the plates with a distinctive yellowgold color is indicative of glycopeptidolipids (3, 5) . On the other hand, the disappearance of the distinctive lipids evident in untreated extracts suggests alkali-labile, presumably lipooligosaccharide, antigens (4, 8) . According to this criterion, M. simiae I and II, M. chelonei subspp. abscessus and chelonei, and M. fortuitun biovariant peregrinum contain alkali-stable glycopeptidolipid antigens; as indicated above, the glycopeptidolipid antigens of M. chelonei subspp. abscessus and chelonei are identical (13) . When the products from the alkali treatment step were examined by ELISA, it was found that they had retained full activity (Table 4) . Thus, the combination of alkalinolysis and ELISA, so suitable for MAIS complex serovars, is also applicable to M. chelonei, M. simiae I and Il, and, with reservations, M. fortuitum biovariant peregrinum. The problem of extensive cross-reactivity which characterizes the glycolipid antigens and antiserum of M. fortuitum biovariant peregrinum were only partially overcome by extensive dilution ( simiae Il cross-reacted with antisera to serovars 1, 2, 3, 6, and 18; antisera to serovars 1, 3, and 6 were already shown to be highly reactive against several MAIS complex serovars. The observation of cross-reactivity between M. simiae II and serovar 18 may be significant since Boisvert and Truffort (1) noted, among other similarities, that M. simiae Il agglutinates serovar 18 antiserum. The M. chelonei subsp. abscessus antiserum cross-reacted slightly with the glycolipid from serovar 1, whereas M. chelonei subsp. chelonei antiserum showed no cross-reactivity against any of the MAIS complex serovars. Conversely, the glycolipid from M. chelonei subspp. abscessus and chelonei showed cross-reactivity only with the highly reactive antisera to MAIS complex serovars 1, 3, and 6.
